NT-proBNP
|
Baseline NT-proBNP
|
-0.699
|
<.001
|
-0.695
|
<.001
|
|
PCI versus med
|
-6.939
|
0.979
|
-253.604
|
0.162
|
|
Famliy history of CAD
|
-511.007
|
0.052
|
-448.534
|
0.015
|
|
New Q waves
|
-531.444
|
0.067
|
-
|
-
|
VEGF
|
Baseline VEGF
|
-0.750
|
<.001
|
-0.727
|
<.001
|
|
PCI versus med
|
-42.952
|
0.109
|
-5.514
|
0.694
|
|
History of cerebrovascular disease
|
-108.966
|
0.065
|
-
|
-
|
|
Current smoker
|
-53.395
|
0.049
|
-
|
-
|
|
Thrombolytic therapy
|
220.645
|
0.026
|
171.550
|
<0.001
|
MMP-2
|
Baseline MMP-2
|
-0.982
|
<.001
|
-0.979
|
<.001
|
|
PCI versus med.
|
-51.316
|
0.351
|
-11.677
|
0.384
|
|
systolic blood pressure (10 mmHg)
|
40.239
|
0.079
|
-
|
-
|
|
diastolic blood pressure (10 mmHg)
|
62.034
|
0.053
|
-
|
-
|
MMP-9
|
Baseline MMP-9
|
-0.751
|
<.001
|
-0.742
|
<.001
|
|
PCI versus med.
|
-24.601
|
0.436
|
0.526
|
0.981
|
|
MI history
|
122.755
|
0.081
|
104.471
|
0.032
|
|
History of cerebrovascular disease
|
-185.871
|
0.006
|
-
|
-
|
|
Current smoker
|
-58.054
|
0.068
|
-
|
-
|
TIMP-2
|
Baseline TIMP-2
|
-0.919
|
<.001
|
-0.885
|
<.001
|
|
PCI versus med.
|
0.412
|
0.914
|
-2.558
|
0.255
|
|
Male versus Female
|
8.349
|
0.049
|
-
|
-
|
|
History of Renal Insufficiency
|
17.714
|
0.085
|
22.685
|
0.003
|
|
Family history of CAD
|
6.314
|
0.099
|
-
|
-
|
|
Current smoker
|
-7.321
|
0.056
|
-5.025
|
0.029
|
|
Heart rate (10 beats/minute)
|
3.213
|
0.099
|
3.566
|
0.002
|
|
BMI (10 kg/m2)
|
-9.403
|
0.087
|
-11.541
|
<0.001
|
GALECTIN
|
Baseline GALECTIN
|
-0.82
|
<.001
|
-0.77
|
<.001
|
|
PCI versus med.
|
-0.734
|
0.674
|
0.037
|
0.975
|
|
Angina history
|
-3.418
|
0.087
|
-
|
-
|
|
PCI history
|
6.348
|
0.059
|
-
|
-
|
|
Thrombolytic therapy
|
-13.353
|
0.040
|
-10.305
|
0.023
|
|
BMI (10 kg/m2)
|
8.281
|
<0.001
|
7.326
|
<.001
|
|
Ejection fraction (10%)
|
-1.983
|
0.018
|
-
|
-
|